🇺🇸 FDA
Patent

US 7928079

Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

granted A61KA61K47/549A61K47/61

Quick answer

US patent 7928079 (Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K47/549, A61K47/61, A61P, A61P27/00